BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2021 10:51:03 AM | Browse: 378 | Download: 858
 |
Received |
|
2021-01-28 23:56 |
|
Peer-Review Started |
|
2021-01-29 00:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-24 04:28 |
|
Revised |
|
2021-04-01 01:45 |
|
Second Decision |
|
2021-04-15 07:26 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-21 14:08 |
|
Articles in Press |
|
2021-04-21 14:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-04-28 02:51 |
|
Typeset the Manuscript |
|
2021-05-31 11:14 |
|
Publish the Manuscript Online |
|
2021-06-08 10:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Segundo Moran, Marlene López-Sánchez, María del Pilar Milke-García and Gustavo Rodríguez-Leal |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Mexican Institute of Social Security |
FFIS/IMSS/PROT/G16/1589 |
| National Council for Science and Technology (CONACYT) |
SALUD-2014-C01-233823 |
|
| Corresponding Author |
Segundo Moran, PhD, Doctor, Laboratory of Hepatology Research, Centro Médico Nacional, Siglo XXI, Mexican Institute of Social Security, Cuauhtemoc 330, Mexico 06720, Mexico. segundomoran@hotmail.com |
| Key Words |
Minimal hepatic encephalopathy; Sarcopenia; Probiotics; Non absorbable disaccharides, Rifaximin; L-ornithine-L-aspartate |
| Core Tip |
Minimal hepatic encephalopathy (MHE) is a frequent complication in patients with liver cirrhosis. MHE affects the quality of life and increases the risk of falls and car accidents, worsening these patients’ prognoses. However, there is no standard of care. Current alternatives for the management of MHE include measures to maintain the nutritional status while avoiding sarcopenia, manipulation of intestinal microbiota with non-absorbable disaccharides such as lactulose, antibiotics such as rifaximin, and administration of different probiotics. This review analyzes the results of clinical studies that evaluated the effect of different treatments for MHE. |
| Publish Date |
2021-06-08 10:51 |
| Citation |
Moran S, López-Sánchez M, Milke-García MDP, Rodríguez-Leal G. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis. World J Gastroenterol 2021; 27(22): 3050-3063 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i22/3050.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i22.3050 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
